PsychoTronic

http://rexresearch.com/1index.htm#antig

Anti-Gravity / Astronautics : AQUINO : Quantum-G Spacecraft ** BROWN (T.T.) : Gravitator ** BROWN (T.T.) : Notebooks (Vol. 1) ** (Vol. 2) ** (Vol. 4) ** BROWN, TT : Journals & Notes - Addendae ** BULL : Inertial Propulsion ** BRUSH : Kinetic G ** CARR : Utron ** COOK : Inertial Propulsion ** DEAN : Inertial Drive ** DESEVERSKY, Major : Ionocraft ** DOTTO : Diamagnetic Levitation ** Electrogravitics ** FARROW : Gravity Reduction ** FETTA : Microwave Space Drive ** FISCHBACH : Hypercharge ** Force Field Propulsion ** GREBENNIKOV : Insect Anti-G (#1) ** GREBENNIKOV : Insect Anti-G (#2) ** HIDDINK : 1-Terminal Capacitor ** HOLLINGSHEAD : Gravitational Lense ** HOOPER : Motional E-Field ** HUTCHISON : Hutchison Effect ** KIDD : Gyroscopic Propulsion ** KOWSKY / FROST : Gravity Nullification ** LAITHWAITE : Gyroscopic Levitation ** MILKOVIC : Two-Stage Mechanical Oscillator ** NIPHER : Electro-G ** PAGES : Antigravity ** PARR : Pyramid Energy ** PERL : Gravitics ** PIGGOTT : Electro-Gravitation ** RAVATIN : Activators ** ROSCHIN / GODIN : Searl Effect ** ROSCHIN / GODIN : Prototype SE Generator ** ROSCHIN & GODIN : Searl Effect Generator ( #3 ) ** ROTA : Levitation Apparatus ** ST. CLAIR : USP Applications ** SARGOYTCHEV : Antigravity ** SEARL : Searl Effect ** SEIKE : G-Strain Amplifier / Monopolar Moebius Coil ** SHAWYER : Microwave Space Drive ** SMITH : Anti-G ** SMITH : G-Control ** Space Drives ** THORNSON : Inertial Engine ** TOMION : Electrodynamic Field Generator ** VIALLE : Negative Mass ** WALLACE : Kinemassic Force ** WHITTAKER : Scalar Potentials **

rexresearch.com/adept/aai2vsb.htm

P. Allen ~ A Christian Rosenkreutz Anthology
Anonymous ~ The Allegory of Merlin
Anon. ~ On the Philosophers' Stone
Anon. ~ Rosarium Philosophorum
Anon. ~ Untitled
S. Bacstrom ~ The Work of Pontanus, According to Mr. F.
D. Beuther ~ The Transmutation of Base Metals...
P. Bonus ~ The New Pearl of Great Price
Cyliani ~ Hermes Unveiled
A. Eleazar ~ The Book of Abraham the Jew
B. Figulus ~ A Golden and Blessed Casket of Nature's Marvels
Fulcanelli ~ The Mystery of the Cathedrals
Fulcanelli ~ The Dwelling of the Philosophers
J. Grashof ~ The Greater & Lesser Edifyer
C. Grummet ~ Sanguis Naturae
J. Helvetius ~ The Golden Calf
J. I. Hollandus ~ De Lapide Philosophorum
J. I. Hollandus ~ Vegetable Work
K. Jnana ~ Dictionary of Alchemical Philosophy
N. LeFebre ~ Secret of Secrets
R. Lully ~ Letter or Epitome to King Rupert
J. Muller ~ Hyle and Coahyl
Myriam ~ Her Conversation with Aros, King of Egypt
Paracelsus ~ The Philosophical Canons
Eir. Philalethes ~ An Open Entrance to the Closed Palace of the King
Eir. Philalethes ~ Ripley Revived
Eug. Philalethes ~ A Short Enquiry Concerning the Hermetic Art
G. Ripley ~ Medulla Alchemiae
M. Rulandus ~ A Lexicon of Alchemy
S. Salztal ~ Fountain of Philosophical Salts
Theophrastus ~ The Sacred Art
Arnold de Villanova ~ Rosarium Philosophorum

rexresearch.com/adept/aa7hgau.htm
Transmutations of Mercury
(1) H. Nagaoka, et al.
(2) F. Tausend
(3) R. Caro & Kamala-Jnana
(4) References

rexresearch.com/adept/aa2ore.htm
Transmutation of Ores
(1) T. Moray
(2) Dunikovski
(3) A. Klobasa
(4) D. Hudson
(5) J. Champion
(6) References

The Dwellings of the Philosophers by Fulcanelli www.cista.net/Houses/main.htm

The simplest archemic process consists in using the effect of violent reactions --- that of acids on bases --- so as to provoke, in the midst of the effervescence, the reunion of the pure parts, their irreducible combination under the form of new bodies. It is then possible, from a metal close to gold --- silver preferably --- to produce a small quantity of the precious metal. Here is, in this order of experiments, an elementary operation whose success we certify provided our instructions are closely followed.

Pour into a tall tubular glass retort a third of its capacity of pure nitric acid. Attach to it a receiver with an exhaust tube and set the apparatus on a sand bath. Operate under a fume hood. Heat the apparatus gently without reaching the boiling point of the acid. Then stop the heat, open the neck and introduce a thin fraction of virgin or cupeled silver that contains no traces of gold. When the emission of nitric peroxide ceases and the effervescence has calmed down, allow a second portion of pure silver to fall into the liquor. Thus repeat the introduction of the metal, without haste, until the boiling and emission of red fumes manifest only little energy, signs of approaching saturation. Add nothing more, Let it settle for a half hour, then cautiously decant your clear, still-warm solution into a beaker. You will find at the bottom of the retort a thin deposit in the form of fine black sand. Wash it with lukewarm distilled water and let it drop into a small porcelain capsule. You will find out through testing that this precipitate is insoluble in hydrochloric acid, as it is in nitric acid. Aqua regia dissolves it and yields a magnificent yellow solution, absolutely similar to that of gold trichloride. Dilute this liquor with distilled water; precipitate it with a sliver of zinc; an amorphous powder, very fine, dull, of reddish-brown coloration will be deposited, identical with that given by natural gold reduced in the same manner. Properly wash, and then dry this powdery precipitate. By pressing it on a sheet of glass or marble, you will get a brilliant, coherent lamina, of a beautiful yellow shine in reflection, of a green color in transparency, having the appearance and the superficial characteristics of the purest gold.

In order to augment your minute deposit with a new quantity, you can do this operation as many times as you wish. In this case, take again the clear silver nitrate solution, diluted by the waters of the first washing; reduce the metal with zinc or copper; decant and abundantly wash when the reduction is complete. Dry this powdery silver and use it for your second dissolution. By continuing in this manner, you will amass enough metal to render the analysis much easier. Furthermore, you will be assured of its true production --- even if the silver that you originally used had some traces of gold.

Among the archemists who used gold to augment it, making use of formulas which led them to success, we will note the Venetian priest Pantheus (12); Naxagorus, author of Alchymia Denudata (1715); de Locques; Duclos; Bernard de Labadye; Joseph du Chesne, baron of Morance, appointed physician to King Henry IV of France; Blaise de Vigenere; Bardin, of Le Havre (1638); Mlle. De Martinville (1610); Yardley, the English inventor of a process which he transmitted to Monsieur Garden, glover in London, in 1716, and later communicated by Monsieur Ferdinand Hockley to Dr Sigismond Bacstrom (13), and which became the object of a letter from the latter to M. L. Sand in 1804; finally, the pious philanthropist, St Vincent de Paul..

If you just want an overunity experiment,
then by all means repeat
(or have your university repeat) Bohren's experiment,
which gives 18 times as much energy out as you put in.

Does it every time, any time, anywhere.

See Craig F. Bohren,
"How can a particle absorb more than the light incident on it?"
American Journal of Physics, 51(4), Apr. 1983, p. 323-327.

Under nonlinear conditions, a particle can absorb more energy than is in the light incident on it.

Metallic particles at ultraviolet frequencies are one class of such particles and insulating particles at infrared frequencies are another.
See also H. Paul and R. Fischer, (Comment on “How can a particle absorb more than the light incident on it?’},
” Am. J. Phys., 51(4), Apr. 1983, p. 327
which replicated the Bohren experiment independently and validated its results !!!

How can a particle absorb more than the light incident on it?
Craig F. Bohren
http://scitation.aip.org/content/aapt/journal/ajp/51/4/10.1119/1.13262
Am. J. Phys. 51, 323 (1983);
http://dx.doi.org/10.1119/1.13262

Practical Guide to Free-Energy Devices

http://www.free-energy-info.co.uk/

Many people have produced devices and ideas for tapping this energy. The energy is often called "Zero-Point Energy" because it is the energy which would remain if a system has it's temperature lowered to absolute zero. This presentation is introductory information on what has already been achieved in this field: devices which output more power than they require to run. This looks as if they contradict the Law of Conservation of Energy, but they don't, and you can see this when you take the zero-point energy field into account.

The material on this web site describes many different devices, with diagrams, photographs, explanations, pointers to web sites, etc. As some of the devices need an understanding of electronic circuitry, a simple, step-by-step instruction course in electronics is also provided in Chapter 12. This can take someone with no previous knowledge of electronics, to the level where they can read, understand, design and build the type of circuits used with these devices.

The main information on this web site has been gathered together into a standard book format.
You can download the main set of information, including the patents, as an eBook, using this link eBook Release 30.4.
The document contains some 3,000 pages and has a file size of about 48 Mb

http://www.free-energy-info.co.uk/PJKbook.pdf

http://www.free-energy-info.co.uk/Chapt16.html

Devices which are the easiest to build :

The Magnetic Frame of Lawrence Tseung (chapter 3)
The Transformers of Thane Heins (chapter 3)
Stephan Leben’s adaptation of the Flynn Magnetic Frame (chapter 3)

These three devices have no moving parts and their performance has to be determined by measurements of the input power and the output power. They all operate by passing a fluctuating magnetic field through a frame, which is typically made from thin strips of laminated steel. These devices are limited in their power levels by the amount of magnetic flux which can be carried by their magnetic frames, and to a much lesser extent, by the maximum current which can be carried by the coil windings placed on those frames. Once the core reaches magnetic saturation, applying a stronger magnetic field to it has no effect at all and just wastes the additional power. So, in order to get any form of powerful output, the magnetic frame or core needs to have a high magnetic capacity, which typically means that the frame has to be big, which in turn, means it will probably be heavy and it may be expensive. Using specialised materials for the core could make a major difference, but most constructors will not have access to any of these nanocrystalline materials.

When properly constructed and operated, these devices can certainly show you that COP>1 is definitely possible.

However, as the results are based on measurements, it is generally difficult to convince anyone else as many people will presume that you are operating a hoax as they have always been taught that any such operation is “impossible” as there is no such thing as “a free lunch”.

If you do want to comment on the input and output power levels, then be sure to measure the DC voltage and the DC current on both the input and the output as it will be argued that any form of waveform will give measurement errors.

The most convincing thing is if the device supplies it’s own input power as well as supplying some additional item, even a single LED.

Where the COP is greater than 1, this should be possible, but to keep the device operating steadily, I suggest that you use a voltage-stabilised circuit to supply the input power as that prevents a runaway situation where increased output power produces increased input power and a positive feedback is created which could lead to the almost instant destruction of circuit components which have been driven well past their rated values.

quote:

---

θα σου έλεγα, ότι εκείνη η προσπάθεια μάζεψε μόνο 48 επενδυτές και 7000 ευρώ σαν κεφάλαιο
(αυτό ήταν το τρομερό ποσό που μαζέψαμε όσα μαζέψαμε)
και βέβαια τα χρήματα αυτά δεν ήταν ικανά να υλοποιήσουν τίποτα.

---

rexresearch.com/adept/aa7hgau.htm
Transmutations of Mercury
(1) H. Nagaoka, et al.
(2) F. Tausend
(3) R. Caro & Kamala-Jnana
(4) References

rexresearch.com/adept/aa2ore.htm
Transmutation of Ores
(1) T. Moray
(2) Dunikovski
(3) A. Klobasa
(4) D. Hudson
(5) J. Champion
(6) References

The Dwellings of the Philosophers by Fulcanelli www.cista.net/Houses/main.htm

The simplest archemic process consists in using the effect of violent reactions --- that of acids on bases --- so as to provoke, in the midst of the effervescence, the reunion of the pure parts, their irreducible combination under the form of new bodies. It is then possible, from a metal close to gold --- silver preferably --- to produce a small quantity of the precious metal. Here is, in this order of experiments, an elementary operation whose success we certify provided our instructions are closely followed.

Pour into a tall tubular glass retort a third of its capacity of pure nitric acid. Attach to it a receiver with an exhaust tube and set the apparatus on a sand bath. Operate under a fume hood. Heat the apparatus gently without reaching the boiling point of the acid. Then stop the heat, open the neck and introduce a thin fraction of virgin or cupeled silver that contains no traces of gold. When the emission of nitric peroxide ceases and the effervescence has calmed down, allow a second portion of pure silver to fall into the liquor. Thus repeat the introduction of the metal, without haste, until the boiling and emission of red fumes manifest only little energy, signs of approaching saturation. Add nothing more, Let it settle for a half hour, then cautiously decant your clear, still-warm solution into a beaker. You will find at the bottom of the retort a thin deposit in the form of fine black sand. Wash it with lukewarm distilled water and let it drop into a small porcelain capsule. You will find out through testing that this precipitate is insoluble in hydrochloric acid, as it is in nitric acid. Aqua regia dissolves it and yields a magnificent yellow solution, absolutely similar to that of gold trichloride. Dilute this liquor with distilled water; precipitate it with a sliver of zinc; an amorphous powder, very fine, dull, of reddish-brown coloration will be deposited, identical with that given by natural gold reduced in the same manner. Properly wash, and then dry this powdery precipitate. By pressing it on a sheet of glass or marble, you will get a brilliant, coherent lamina, of a beautiful yellow shine in reflection, of a green color in transparency, having the appearance and the superficial characteristics of the purest gold.

In order to augment your minute deposit with a new quantity, you can do this operation as many times as you wish. In this case, take again the clear silver nitrate solution, diluted by the waters of the first washing; reduce the metal with zinc or copper; decant and abundantly wash when the reduction is complete. Dry this powdery silver and use it for your second dissolution. By continuing in this manner, you will amass enough metal to render the analysis much easier. Furthermore, you will be assured of its true production --- even if the silver that you originally used had some traces of gold.

Among the archemists who used gold to augment it, making use of formulas which led them to success, we will note the Venetian priest Pantheus (12); Naxagorus, author of Alchymia Denudata (1715); de Locques; Duclos; Bernard de Labadye; Joseph du Chesne, baron of Morance, appointed physician to King Henry IV of France; Blaise de Vigenere; Bardin, of Le Havre (1638); Mlle. De Martinville (1610); Yardley, the English inventor of a process which he transmitted to Monsieur Garden, glover in London, in 1716, and later communicated by Monsieur Ferdinand Hockley to Dr Sigismond Bacstrom (13), and which became the object of a letter from the latter to M. L. Sand in 1804; finally, the pious philanthropist, St Vincent de Paul..

quote:

---

... ετσι συνεχισαμε με χημειοθεραπεια σε μορφη χαπιων.....
.... ξαφνικα ομως η μητερα μου σιγα σιγα αρχισε να μπερδευει τα λογια της κ να ξεχναει σε σημειο που τωρα να μην καταλαβαινουμε πολλες φορες τι λεει.

---

Transmutations of Mercury rexresearch.com/adept/aa7hgau.htm
(1) H. Nagaoka, et al.
(2) F. Tausend
(3) R. Caro & Kamala-Jnana
(4) References

Transmutation of Ores rexresearch.com/adept/aa2ore.htm
(1) T. Moray
(2) Dunikovski
(3) A. Klobasa
(4) D. Hudson
(5) J. Champion
(6) References

The Dwellings of the Philosophers by Fulcanelli www.cista.net/Houses/main.htm

The simplest archemic process consists in using the effect of violent reactions --- that of acids on bases --- so as to provoke, in the midst of the effervescence, the reunion of the pure parts, their irreducible combination under the form of new bodies. It is then possible, from a metal close to gold --- silver preferably --- to produce a small quantity of the precious metal. Here is, in this order of experiments, an elementary operation whose success we certify provided our instructions are closely followed.

Pour into a tall tubular glass retort a third of its capacity of pure nitric acid. Attach to it a receiver with an exhaust tube and set the apparatus on a sand bath. Operate under a fume hood. Heat the apparatus gently without reaching the boiling point of the acid. Then stop the heat, open the neck and introduce a thin fraction of virgin or cupeled silver that contains no traces of gold. When the emission of nitric peroxide ceases and the effervescence has calmed down, allow a second portion of pure silver to fall into the liquor. Thus repeat the introduction of the metal, without haste, until the boiling and emission of red fumes manifest only little energy, signs of approaching saturation. Add nothing more, Let it settle for a half hour, then cautiously decant your clear, still-warm solution into a beaker. You will find at the bottom of the retort a thin deposit in the form of fine black sand. Wash it with lukewarm distilled water and let it drop into a small porcelain capsule. You will find out through testing that this precipitate is insoluble in hydrochloric acid, as it is in nitric acid. Aqua regia dissolves it and yields a magnificent yellow solution, absolutely similar to that of gold trichloride. Dilute this liquor with distilled water; precipitate it with a sliver of zinc; an amorphous powder, very fine, dull, of reddish-brown coloration will be deposited, identical with that given by natural gold reduced in the same manner. Properly wash, and then dry this powdery precipitate. By pressing it on a sheet of glass or marble, you will get a brilliant, coherent lamina, of a beautiful yellow shine in reflection, of a green color in transparency, having the appearance and the superficial characteristics of the purest gold.

In order to augment your minute deposit with a new quantity, you can do this operation as many times as you wish. In this case, take again the clear silver nitrate solution, diluted by the waters of the first washing; reduce the metal with zinc or copper; decant and abundantly wash when the reduction is complete. Dry this powdery silver and use it for your second dissolution. By continuing in this manner, you will amass enough metal to render the analysis much easier. Furthermore, you will be assured of its true production --- even if the silver that you originally used had some traces of gold.

Among the archemists who used gold to augment it, making use of formulas which led them to success, we will note the Venetian priest Pantheus (12); Naxagorus, author of Alchymia Denudata (1715); de Locques; Duclos; Bernard de Labadye; Joseph du Chesne, baron of Morance, appointed physician to King Henry IV of France; Blaise de Vigenere; Bardin, of Le Havre (1638); Mlle. De Martinville (1610); Yardley, the English inventor of a process which he transmitted to Monsieur Garden, glover in London, in 1716, and later communicated by Monsieur Ferdinand Hockley to Dr Sigismond Bacstrom (13), and which became the object of a letter from the latter to M. L. Sand in 1804; finally, the pious philanthropist, St Vincent de Paul..

quote:

---

Σας Ικετεύω να με διψεύσετε.
Ευχαριστώ εκ των προτέρων, Αγγελος.

---

Chemotherapy Almost Useless in Treating Advanced Organic Cancer—

Provocative Theses at the Hamburg Cancer Congress

Article from Der Spiegel, 33/1990, 174-176

(Translation provided by People Against Cancer, Otho, Iowa)

For ten years Ulrich Abel, 38, has served the West German cancer doctors as a “number cruncher” (his own expression). This graduate mathematician and PhD in epidemiology has been helping clinicians carry out their cancer investigations.
His knowledge of method was in demand and his relations with cancer
experts were excellent. This past spring, however, the Heidelberg biostatistician himself took up pen and brought out a smart book with the title:

Cytostatic Therapy of Advanced Epithelial Tumors — A Critique (Hippocrates Verlag, Stuttgart. 112 pages. 28 marks).

Since that time Abel has become a Cain for many West German cancer
specialists. Abel admits that in some cases he is “no longer invited
to participate” in new research.
For a year this researcher, working in the Heidelberg/Maanheim Tumor Center looked through essentially “a11 the literature” that deals with chemotherapy (“several thousand articles”).

The findings of foreign chemotherapy researchers were perused by Abel as pertinaciously as those of West German oncologists. In addition, he sent self-addressed envelopes to 350 cancer experts and cancer centers everywhere in the world in order to track down additional anti-tumor medication research which had
not yet appeared in the cancer (oncology) journals.

Abel expresses in a single word the outcome of his research: “appalling.”

In the light of his year-long investigation, Abel concludes that “faith in the efficacy of chemotherapy” in the brains of many physicians is clearly a “fixed dogma” which cannot withstand the acid test of strict science.

What for this employee of the Heidelberg Tumor Center was “initially just a suspicion” became a “certainty” when be had finally put the puzzle together: the weapon of chemotherapy has remained dull in the hands of cancer fighters; even after decades of clinical application and therapeutic research the cellular poisons (cytostatics)
of cancer therapy “in broad areas” of cancer therapy have “misfired.”

The scientist’s findings show that most kinds of cancer treatment, which are so productive of side effects, are disappointing for the patient, and for two reasons:

Chemotherapy is incapable of extending in any appreciable way the lives of patients suffering from the most common organic cancers.

Even the palliative effect of these medications, supposedly improving the quality of life of the patient, rests on shaky scientific ground.

The Heidelberg renegade could have been described as frivolous if his exposure of chemotherapy had not turned out to be appropriately differentiated. For nothing is harder for physicians in daily clinical practice than to dispel the inevitable
fears of patients about chemotherapy. Hence the tumor researcher shrugs off reproaches made against his book by some West German cancer bigwigs, even before it had seen the light.

Abel’s verdict against the medicinal treatment of cancer is emphatically untrue for various kinds of lymph cancer, Hodgkin’s disease, leukemias, sarcomas, and
testicular cancers in the male. These kinds of malignancies can be cured by chemotherapy with a high degree of probability, especially in children — an undisputed success. But these are, in any case, only a very small part of the new cases of cancer diagnosed every year.

Abel’s doubts are not directed against chemotherapy when it is used in support of a curative operation, in order to shrink the tumor beforehand; nor do they apply to
chemotherapy used prophylactically after an operation, to prevent a relapse (as an adjuvant).

“A scientific wasteland” is how Abel describes the chemotherapy of advanced epithelial malignancies.” This group includes almost all organic cancer in which a potentially curative operation is no lodger possible, because the tumor has already
metastasized, or has recurred after a course of treatment (relapse).
These kinds of tumors constitute at least 80% of all deaths from cancer every year.

In advanced small-cell lung cancer it is possible that cellular poisons may extend life somewhat. But the benefit is very slight — several months on the average.

And neither in breast cancer nor in stomach cancer, neither in intestinal, bladder, or pancreatic cancer is this true when the case is advanced and metastasized. The low efficacy of medicinal antitumor therapy, in the view of the Heidelberg researcher, “is something of which neither the public nor the greater’ part of practicing physicians are particularly aware.”

According to Abel, chemotherapy is recognizably not in a position to appreciably prolong the lives of patients. At least, there is no conclusive scientific evidence for it. Such evidence will become available when the survival rates of patients under chemotherapy can be systematically compared with those of untreated cancer patients within the framework of controlled clinical trials.

But such a procedure has no chance of acceptance by ethics commissions made up of physicians. “One cannot leave untreated a patient whose cancer is treatable with chemotherapy,” state the West German experts, Dieter Karl Hossfeld and Albrecht
Pfleiderer, “just to find out if he might not survive just as long without therapy. The benefits of chemotherapy are assumed axiomatically but not proven.

Also the fact that under chemotherapy the tumor mass shrinks or temporarily disappears completely) partial or complete remission) is, in Abel’s view not a good sign. For the remaining tumor cells which resist the effect of the medication
sometimes grow much faster afterwards.

A connection between “response,” meaning shrinking of the tumor tissue, and improved survival, which many physicians see as the justification for chemotherapy, cannot be documented in the literature. “Surprisingly often” the Heidelberg biostatistician finds the opposite occurs: patients in whom the medicine had no
effect on the tumor survive longer.

According to Abel’s findings, the second axiom of chemotherapy, the palliative effects of cytostatic medicines, also rests on scientifically shky ground.

Reliable studies, which might substantiate this belief for the majority of patients (exceptions are possible), according to Abel “are not yet to be found.” The leas one can say is that older research in the 1970s reached the opposite conclusion:
highly aggressive chemotherapy undertaken prematurely (in, for
examples patients with lung cancer) shortened the survival time as
compared with patients in whom chemotherapy was first instituted
only with the onset of pain and which was conducted less
aggressively.

The is FDA has yet to license a cancer remedy on the basis of improved quality of life, since no evidence in support of such a claim has yet been demonstrated.

Despite this, according to the observations of the Heidelberg scientist, tumor patients are often bombarded with cellular poisons at a time when the tumor in the body is still
painless.

Some of the reasons for the “routine” use of toxic assaults on the body, Abel maintains, have to do with a diffuse “belief” of physicians in the efficacy of their therapy. Above all, badly informed physicians start with the attitude, often urged on by
their desperate patients that they should commence with an “aggressive therapy causing many side effects” “at an early stage” and without the patient himself complaining “substantial pain.”

Behind this willingness of clinicians to fire away there is often a compulsion to conduct research. Patients who are not suffering any pain are dragged at an early stage into chemotherapy because their treatment can be conducted as part of a clinical trial; but here, in Abel’s view, it is hardly possible to give the patient an “individualized therapy, oriented toward his own specific complaints.”

Aggressive doses of cytostatics, moreover meet the
physician’s need for legitimation. The higher the dose, the better
the prospect that the tumor will shrink under the effect of the
cellular poison; hence maximal therapies often have the desired
outcome. A victory over the tumor seems to have been reached when it
remits partially or completely — even though ultimately this is no
victory for the patient it all. States Abel, “There is not yet any
perceptible tendency in medicine to refrain from trials with high
doses.”

The chemotherapy of advanced organic cancer is
stuck in a blind alley out of which “an exit will be achieved only
in small steps and not without some painful insights.” Oncology, as
the researcher puts it, has “up until now failed to provide an
unobjectionable scientific basis for cytostatic therapy in its
presently dominant form.

The thesis of the efficacy of cellular poisons,
and the “overwhelming dominance of chemotherapeutic researched”
which it has spawned, may, in Abel’s judgment, be seen in the future
as “one of the greatest missteps ever taken in oncology and the one
with the most tragic consequences.

The change of direction which is “urgently needed”
in the patient’s interests runs smack up against the various
structures which have been erected in the meantime. About 90% of
research capacity, in Abel’s view, is tied in with ongoing
chemotherapeutic investigations. The earnings of the pharmaceutical
industry from anti-tumor medications amount to half a billion marks
every year. Many cancer researchers get up to 1000 marks from the
suppliers for each documented case they treat.

Alternative methods of treatment, such as possibly
immune therapy, scarcely make it into the running; since many
physicians lack knowledge of them. “Research proposals along these
lines,” as Able ascertained over and over again during his years of
consulting work, hardly get a hearing in new research plans.

So the other side has a hard time getting to the
table. The advocates of immunotherapeutic approaches, or of certain
other unconventional anticancer methods, are generally reluctant to
let their therapies be tested in comparison with chemotherapy in
controlled clinical trials.

Thus certain questions whose answers would be very important for the patients remain in a scientifically gray area:

Do chemotherapeutic techniques promise
greater success in the treatment of advanced organic cancer than
the less toxic immune therapies which also have fewer side
effects?
Do patients who are not treated at all come out better in the end?
Is it sufficient if cytostatic medicines are
first prescribed only when the patient’s pain becomes severe?
Can low doses of chemotherapeutic agents not
basically improve the patient’s outcome?
Only a “lack of scientific imagination” as Abel
thinks, has hindered the clarification of these questions up to now.
One of his proposed models might serve to lift the veil of secrecy:
patients with advanced organic cancer who are not yet in pain from
their tumor could be tested in two groups. One group would receive
cytostatic agents, the other immunotherapeutic remedies. The ethical
dilemma could be resolved by giving the patients in the second group
chemotherapeutic agents if the onset or symptoms demands it.
Biostatistician Abel stands too close to the
rational ideal of his mathematical discipline for his criticism of
chemotherapy to be characterized as “advocacy of dubious therapies.”
He was forced into this reckoning by the dogmatic rigidity of the
chemotherapists and their “excessive optimism.” Says Abel: “they are
painting themselves into a corner.”

Those who have been scolded by him have up to now given the erstwhile number cruncher short shrift. More recently, as Abel’s cynicism has been more and more perceptible between the lines, oncologist Hossfeld and Pfleiderer have “ended all readiness for dialog with the author.

Perhaps there is more openness to dialog on the part of foreign tumor experts. At the Fifteenth International Cancer Congress, which opens Thursday of this week in Hamburg with about 8,000 specialists from all over the world, the book of Cain will be available in an English translation.

Transmutations of Mercury : rexresearch.com/adept/aa7hgau.htm
(1) H. Nagaoka, et al.
(2) F. Tausend
(3) R. Caro & Kamala-Jnana
(4) References

Transmutation of Ores : rexresearch.com/adept/aa2ore.htm
(1) T. Moray
(2) Dunikovski
(3) A. Klobasa
(4) D. Hudson
(5) J. Champion
(6) References

It is then possible,from a metal close to gold silver preferably to produce a small quantity of the precious metal.

Here is, in this order of experiments, an elementary operation whose success we certify provided our instructions are closely followed.....

Pour into a tall tubular glass retort a third of its capacity of pure nitric acid. Attach to it a receiver with an exhaust tube and set the apparatus on a sand bath. Operate under a fume hood. Heat the apparatus gently without reaching the boiling point of the acid. Then stop the heat, open the neck and introduce a thin fraction of virgin or cupeled silver that contains no traces of gold. When the emission of nitric peroxide ceases and the effervescence has calmed down, allow a second portion of pure silver to fall into the liquor. Thus repeat the introduction of the metal, without haste, until the boiling and emission of red fumes manifest only little energy, signs of approaching saturation. Add nothing more, Let it settle for a half hour, then cautiously decant your clear, still -warm solution into a beaker. You will find at the bottom of the retort a thin deposit in the form of fine black sand. Wash it with lukewarm distilled water and let it drop into a small porcelain capsule. You will find out through testing that this precipitate is insoluble in hydrochloric acid, as it is in nitric acid. Aqua regia dissolves it and yields a magnificent yellow solution, absolutely similar to that of gold trichloride. Dilute this liquor with distilled water; precipitate it with a sliver of zinc; an amorphous powder, very fine, dull,of reddish-brown coloration will be deposited, identical with that given by natural gold reduced in the same manner. Properly wash, and then dry this powdery precipitate. By pressing it on a sheet of glass or marble, you will get a brilliant, coherent lamina, of a beautiful yellow shine in reflection, of a green color in transparency, having the appearance and the superficial characteristics of the purest gold...

Dwellings of The Philosophers - Fulcanelli,
cista.net/Houses/main.htm

ΕΣΥ Ο,ΤΙ ΚΑΝΕΙΣ ΓΙΑ ΤΟΝ ΕΑΥΤΟ ΣΟΥ !

ΔΕΝ ΘΑ ΣΟΥ ΠΕΙ ΚΑΝΕΙΣ, ΤΟ ΠΩΣ ΔΕΝ ΘΑ ΤΟΝ ΕΧΕΙΣ ΑΝΑΓΚΗ !

ΠΑΡΕ ΤΑ ΧΕΡΙΑ ΣΟΥ ΑΠΟ ΤΟ ΠΛΗΚΤΡΟΛΟΓΙΟ, ΚΑΙ ΠΗΓΑΙΝΕ ΦΤΙΑΞΕ ΚΑΤΙ !

Ο ΟΡΟΣ "Ψευδοεπιστήμη" ΕΙΝΑΙ ΟΡΟΣ ΠΟΛΙΤΙΚΗΣ ΕΠΙΡΡΟΗΣ !
ΕΙΤΕ ΙΣΧΥΕΙ ΚΑΤΙ, ΕΙΤΕ ΔΕΝ ΙΣΧΥΕΙ, ΦΤΙΑΞΕΤΟ, ΓΙΑ ΝΑ ΔΙΑΠΙΣΤΩΣΕΙΣ ΜΟΝΟΣ ΣΟΥ !

ΚΑΙ ΝΑ ΜΗΝ ΠΙΣΤΕΥΕΙΣ ΚΑΝΕΝΑ !

The Civilization Kit : Rex Research was established in 1982 by Robert A. Nelson to archive and distribute " InFolios " -- Information Folios -- of collected Articles about suppressed, dormant, or emerging Sciences, Technologies, Inventions, Theories, Therapies, & other Alternatives that offer real Hope & Choices to help Liberate Humanity from its Stupidity and the evile Pornocracy of Psychopaths .

http://rexresearch.com/1index.htm

rexresearch.com/adept/aa7hgau.htm
Transmutations of Mercury
(1) H. Nagaoka, et al.
(2) F. Tausend
(3) R. Caro & Kamala-Jnana
(4) References

rexresearch.com/adept/aa2ore.htm
Transmutation of Ores
(1) T. Moray
(2) Dunikovski
(3) A. Klobasa
(4) D. Hudson
(5) J. Champion
(6) References

The Dwellings of the Philosophers by Fulcanelli www.cista.net/Houses/main.htm

The simplest archemic process consists in using the effect of violent reactions --- that of acids on bases --- so as to provoke, in the midst of the effervescence, the reunion of the pure parts, their irreducible combination under the form of new bodies. It is then possible, from a metal close to gold --- silver preferably --- to produce a small quantity of the precious metal. Here is, in this order of experiments, an elementary operation whose success we certify provided our instructions are closely followed.

Pour into a tall tubular glass retort a third of its capacity of pure nitric acid. Attach to it a receiver with an exhaust tube and set the apparatus on a sand bath. Operate under a fume hood. Heat the apparatus gently without reaching the boiling point of the acid. Then stop the heat, open the neck and introduce a thin fraction of virgin or cupeled silver that contains no traces of gold. When the emission of nitric peroxide ceases and the effervescence has calmed down, allow a second portion of pure silver to fall into the liquor. Thus repeat the introduction of the metal, without haste, until the boiling and emission of red fumes manifest only little energy, signs of approaching saturation. Add nothing more, Let it settle for a half hour, then cautiously decant your clear, still-warm solution into a beaker. You will find at the bottom of the retort a thin deposit in the form of fine black sand. Wash it with lukewarm distilled water and let it drop into a small porcelain capsule. You will find out through testing that this precipitate is insoluble in hydrochloric acid, as it is in nitric acid. Aqua regia dissolves it and yields a magnificent yellow solution, absolutely similar to that of gold trichloride. Dilute this liquor with distilled water; precipitate it with a sliver of zinc; an amorphous powder, very fine, dull, of reddish-brown coloration will be deposited, identical with that given by natural gold reduced in the same manner. Properly wash, and then dry this powdery precipitate. By pressing it on a sheet of glass or marble, you will get a brilliant, coherent lamina, of a beautiful yellow shine in reflection, of a green color in transparency, having the appearance and the superficial characteristics of the purest gold.

In order to augment your minute deposit with a new quantity, you can do this operation as many times as you wish. In this case, take again the clear silver nitrate solution, diluted by the waters of the first washing; reduce the metal with zinc or copper; decant and abundantly wash when the reduction is complete. Dry this powdery silver and use it for your second dissolution. By continuing in this manner, you will amass enough metal to render the analysis much easier. Furthermore, you will be assured of its true production --- even if the silver that you originally used had some traces of gold.

Among the archemists who used gold to augment it, making use of formulas which led them to success, we will note the Venetian priest Pantheus (12); Naxagorus, author of Alchymia Denudata (1715); de Locques; Duclos; Bernard de Labadye; Joseph du Chesne, baron of Morance, appointed physician to King Henry IV of France; Blaise de Vigenere; Bardin, of Le Havre (1638); Mlle. De Martinville (1610); Yardley, the English inventor of a process which he transmitted to Monsieur Garden, glover in London, in 1716, and later communicated by Monsieur Ferdinand Hockley to Dr Sigismond Bacstrom (13), and which became the object of a letter from the latter to M. L. Sand in 1804; finally, the pious philanthropist, St Vincent de Paul..

Filed under: ΚΑΡΚΙΝΟΣ by ΜΑΡΙΑΝΝΑ ΕΥΑΓΓΕΛΟΥ
Αναρτήθηκε από Terrapapers // 9 Νοεμβρίου 2012

ΔΙΑΒΑΣΕ ΤΟ PDF STH ΣΕΛΙΔΑ 17

το εκανα κοπι-παστ στα αγγλικα

http://www.tbyil.com/VCU_Cancer_Center_Report.pdf

Αλλα και παλι δεν λεει τιποτα, θα επρεπε να λεεI περισσοτερα απο τα αισχη τους,
ολους μας εχουνε υπνωτισμενους το Φαρκευτικο καρτελλ

Unrealistic or uneducated demands for benefit !!!!
( xa xa xa xa xa xa ! αμ δε, που θα το κανει !!! )
Give truthful information !!!!
( xa xa xa xa xa xa ! καλα, περιμενε εσυ !!! )

Breast Cancer, fourth line chemotherapy : What is my chance of being alive at one year if I take chemotherapy, or do best supportive care such as hospice? Without chemotherapy, about 5 of 100 women would be alive at one year. With chemotherapy, about 10 of 100 women would be alive at one year.

The average woman with breast cancer treated with “fourth line chemotherapy ” lived about 5 months.
Half will do better, half worse.

What is the chance of my being cured by chemotherapy ?
In this setting, there is no chance of cure.

ΝΑ ΣΤΟ ΞΑΝΑΠΩ, ΝΑ ΤΟ ΕΜΠΕΔΩΣΕΙΣ !

What is the chance of my being cured by chemotherapy?
……Τhere is no chance of cure.

ΝΑ ΣΤΟ ΞΑΝΑΠΩ, ΝΑ ΤΟ ΕΜΠΕΔΩΣΕΙΣ !

What is the chance of my being cured by chemotherapy?
……Τhere is no chance of cure.

ΝΑ ΣΤΟ ΞΑΝΑΠΩ, ΝΑ ΤΟ ΕΜΠΕΔΩΣΕΙΣ !

What is the chance of my being cured by chemotherapy?
……Τhere is no chance of cure.

The emperor’s new clothes – can chemotherapy survive?

Eva Segelov, Medical Oncologist, St Vincent’s Clinical School, Sydney

Key words: antineoplastics, cancer.

Aust Prescr 2006;29:2-3

‘An Australian study suggests that the benefits of chemotherapy have been oversold … Why has it been oversold? Are you suggesting that medical oncologists in Australia are just sort of marketing shysters or what?’ These were some of the questions posed by Dr Norman Swan when he presented the Health Report on ABC Radio National on 18 April 2005.1 Dr Swan was quizzing Associate Professor Graeme Morgan, the lead author of a controversial article entitled ‘The contribution of cytotoxic chemotherapy to 5-year survival in adult malignancies’.2 This article reported that chemotherapy has improved survival by less than 3% in adults with cancer.

These provocative figures were derived from a literature search of all randomised clinical trials reporting a five-year survival benefit attributable solely to cytotoxic chemotherapy in 22 major adult malignancies. The common malignancies of bowel, lung, breast and prostate were included. The total number of newly diagnosed cancer patients for each malignancy in 1998 was determined from cancer registry data in Australia and the USA. The absolute number to benefit was the product of the total number of patients with that malignancy, the proportion or sub-group(s) with that malignancy showing a benefit, and the percentage increase in five-year survival due solely to cytotoxic chemotherapy. The overall contribution was the sum total of the absolute numbers of patients showing a
five-year survival benefit expressed as a percentage of the total number for the 22 malignancies.

Overall cancer survival, following all kinds of treatment, is approximately 63%. Based on the calculations in the study the contribution of chemotherapy to adult survival from cancer was estimated to be 2.3% in Australia and 2.1% in the USA. The authors, two of whom are radiation oncologists, but one of whom is a practicing professor of medical oncology, concluded that ‘chemotherapy only makes a minor contribution to cancer survival’ and ‘to justify the continued funding and availability of drugs used in cytotoxic chemotherapy, a rigorous evaluation of the cost-effectiveness and impact on quality of life is urgently required’. The paper attracted much attention. In the medical oncology community, there was much outrage and indignation at this ‘misleading and unhelpful’ paper. Associate Professor Michael Boyer, head of medical oncology at Royal Prince Alfred Hospital, Sydney, commented, ‘The fact is that from a patient’s perspective they are not really interested in how much chemotherapy contributes to the cure of all patients, what they are interested in is how much it will contribute to their particular disease and their stage of their disease … I don’t think this paper helps from a patient’s perspective.

Similarly from a public funding, or public policy point of view, lumping everything together is not a terribly helpful way …’.1 Associate Professor Boyer raised concern about the study methodology and the fact that ‘if you start … saying how much does chemotherapy add in the people that you might actually use it [in], the numbers start creeping up … to 5% or 6% …’.1 It is true that the paper used definitions of convenience and excluded certain cancers with high cure rates from chemotherapy, such as leukaemias, childhood cancers and other curable rare cancers. In addition, the study did not account for the contribution of chemotherapy in increasing the efficacy of other modalities, for example in ‘down staging’ before surgery or when used concurrently with radiation. The data set, from 1998, does not reflect recent advances with more modern chemotherapy
drugs, although again their impact on survival is modest.

The article did not aim to address quality of life or other benefits from chemotherapy, or any parameters relating to palliation, which after all is the aim of the great majority of chemotherapy.

It also does not discuss the curative benefit of other drugs in the medical oncology armamentarium, such as hormone therapy or ‘targeted’ drugs, such as bevacizumab or trastuzumab. One should not throw the baby out with the bath water, so to infer that medical oncology has no role in the management of cancer patients would be mischievous. Similarly, the article discusses issues to be considered in the formation of public policy, rather than making any statements on the management of individual patients.

Individual patients are concerned about their own chance of survival. Many patients will accept chemotherapy despite the small absolute benefit in survival.3 A useful tool for adjuvant therapy for breast and bowel cancer, which uses a mathematical model for working out the benefit of chemotherapy, is Adjuvant! (www.AdjuvantOnline.com). Although such a model may show the small benefit, the patients and their families are often seeking a cure if at all possible. Their
concerns are individual and immediate. They want to know the ‘worth’ of chemotherapy, but it is unlikely that the cost of the treatment is ever raised as a factor in an individual patient decision.

Cost only becomes a significant issue if the treatment is not subsidised and the patient has to pay.

We are still left with the finding that the overall contribution of cytotoxic chemotherapy to survival in the 22 cancers reviewed in the study is less than 3%. Is this apparent heresy merely sourgrapes from our radiation colleagues (who have previously shown a 16% survival benefit for radiation therapy4), or could it actually represent something close to the truth? At 2% or 6%, surely the message is the same. Modern Western society, with its obsession with cure at all costs and the focus on the outcome for an individual, has a track record of subverting community welfare on issues relating to ‘big picture’ sustainability.
Failure to come to terms with rationalisation of high cost medicine and the inability to convince multinational pharmaceutical corporations to provide drugs at a sustainable price will mean that our treatments are likely to have less, not more impact in the future, as only a portion of society will be able to afford them. Let us rise to the challenge rather than shrink from the spotlight. We have to hope that in the decades to come the contribution of chemotherapy to survival and well-being is significantly increased. However, we must realise that until we as prescribers, and the community as consumers, recognise our limitations and rationalise our resource utilisation, we may never achieve this goal.

References

1. The health report: chemotherapy [radio program transcript]. http://www.abc.net.au/rn/talks…[cited 2006 Jan 13]

2.Morgan G, Ward R, Barton M. The contribution of cytotoxic chemotherapy to 5-year survival in adult malignancies. Clin Oncol 2004;16:549-60.

3.Lindley CM, Vasa SP, Sawyer WT, Winer EP. Eliciting preferences for adjuvant therapy in patients with early stage breast cancer: tradeoffs between treatment, cure, and survival.
Proceedings of the 31st annual meeting of ASCO; 1995. Abstr 149.

4.Barton MB, Gebski V, Manderson C, Langlands AO. Radiation therapy: are we getting value for money? Clin Oncol (R Coll Radiol) 1995;7:287-92.

rexresearch.com/adept/aa7hgau.htm
Transmutations of Mercury
(1) H. Nagaoka, et al.
(2) F. Tausend
(3) R. Caro & Kamala-Jnana
(4) References

rexresearch.com/adept/aa2ore.htm
Transmutation of Ores
(1) T. Moray
(2) Dunikovski
(3) A. Klobasa
(4) D. Hudson
(5) J. Champion
(6) References

The Dwellings of the Philosophers by Fulcanelli www.cista.net/Houses/main.htm

The simplest archemic process consists in using the effect of violent reactions --- that of acids on bases --- so as to provoke, in the midst of the effervescence, the reunion of the pure parts, their irreducible combination under the form of new bodies. It is then possible, from a metal close to gold --- silver preferably --- to produce a small quantity of the precious metal. Here is, in this order of experiments, an elementary operation whose success we certify provided our instructions are closely followed.

Pour into a tall tubular glass retort a third of its capacity of pure nitric acid. Attach to it a receiver with an exhaust tube and set the apparatus on a sand bath. Operate under a fume hood. Heat the apparatus gently without reaching the boiling point of the acid. Then stop the heat, open the neck and introduce a thin fraction of virgin or cupeled silver that contains no traces of gold. When the emission of nitric peroxide ceases and the effervescence has calmed down, allow a second portion of pure silver to fall into the liquor. Thus repeat the introduction of the metal, without haste, until the boiling and emission of red fumes manifest only little energy, signs of approaching saturation. Add nothing more, Let it settle for a half hour, then cautiously decant your clear, still-warm solution into a beaker. You will find at the bottom of the retort a thin deposit in the form of fine black sand. Wash it with lukewarm distilled water and let it drop into a small porcelain capsule. You will find out through testing that this precipitate is insoluble in hydrochloric acid, as it is in nitric acid. Aqua regia dissolves it and yields a magnificent yellow solution, absolutely similar to that of gold trichloride. Dilute this liquor with distilled water; precipitate it with a sliver of zinc; an amorphous powder, very fine, dull, of reddish-brown coloration will be deposited, identical with that given by natural gold reduced in the same manner. Properly wash, and then dry this powdery precipitate. By pressing it on a sheet of glass or marble, you will get a brilliant, coherent lamina, of a beautiful yellow shine in reflection, of a green color in transparency, having the appearance and the superficial characteristics of the purest gold.

In order to augment your minute deposit with a new quantity, you can do this operation as many times as you wish. In this case, take again the clear silver nitrate solution, diluted by the waters of the first washing; reduce the metal with zinc or copper; decant and abundantly wash when the reduction is complete. Dry this powdery silver and use it for your second dissolution. By continuing in this manner, you will amass enough metal to render the analysis much easier. Furthermore, you will be assured of its true production --- even if the silver that you originally used had some traces of gold.

Among the archemists who used gold to augment it, making use of formulas which led them to success, we will note the Venetian priest Pantheus (12); Naxagorus, author of Alchymia Denudata (1715); de Locques; Duclos; Bernard de Labadye; Joseph du Chesne, baron of Morance, appointed physician to King Henry IV of France; Blaise de Vigenere; Bardin, of Le Havre (1638); Mlle. De Martinville (1610); Yardley, the English inventor of a process which he transmitted to Monsieur Garden, glover in London, in 1716, and later communicated by Monsieur Ferdinand Hockley to Dr Sigismond Bacstrom (13), and which became the object of a letter from the latter to M. L. Sand in 1804; finally, the pious philanthropist, St Vincent de Paul..